Technical Analysis for PRDS - Pardes Biosciences, Inc.
| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Strong | Down | Down | Up |
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| Crossed Above 20 DMA | Bullish | 0.00% | |
| Pocket Pivot | Bullish Swing Setup | 0.00% | |
| Bollinger Band Squeeze | Range Contraction | 0.00% | |
| New Uptrend | Bullish | 7.32% | |
| Bollinger Band Squeeze | Range Contraction | 7.32% | |
| Narrow Range Bar | Range Contraction | 7.32% | |
| Stochastic Reached Oversold | Weakness | 7.32% | |
| BB Squeeze Started | Range Contraction | 7.32% | |
| Oversold Stochastic | Weakness | 7.32% | |
| Earnings Movers | Other | 9.09% |
Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App
| Alert | Time |
|---|---|
| Down 1% | 1 day ago |
| Rose Above Previous Day's High | 1 day ago |
| 10 DMA Resistance | 1 day ago |
| 2x Volume Pace | 1 day ago |
| 1.5x Volume Pace | 1 day ago |
Get this analysis on your stocks daily!
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 03/28/2023
Pardes Biosciences is a clinical-stage biopharmaceutical company created by and for this moment to help solve pandemic-sized problems, starting with COVID-19. We are applying modern reversible-covalent chemistry as a starting point to discover and develop novel oral drug candidates while reimagining the patient journey to access these medicines. The company’s lead product candidate, PBI-0451, is being developed as a direct-acting, oral antiviral drug to treat and prevent SARS-CoV-2 infections, the virus responsible for COVID-19. Pardes Biosciences is on a mission to stop a pandemic and start a movement so patients everywhere can get well sooner.
Sector: Healthcare
Industry: Biotechnology
Keywords: Infectious Diseases Infection Viruses Zoonoses Covid 19 Severe Acute Respiratory Syndrome Coronavirus 2
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Infectious Diseases Infection Viruses Zoonoses Covid 19 Severe Acute Respiratory Syndrome Coronavirus 2
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 8.75 |
| 52 Week Low | 0.75 |
| Average Volume | 134,169 |
| 200-Day Moving Average | 2.07 |
| 50-Day Moving Average | 1.56 |
| 20-Day Moving Average | 1.32 |
| 10-Day Moving Average | 1.28 |
| Average True Range | 0.17 |
| RSI | 46.24 |
| ADX | 26.51 |
| +DI | 28.72 |
| -DI | 11.30 |
| Chandelier Exit (Long, 3 ATRs) | 1.27 |
| Chandelier Exit (Short, 3 ATRs) | 1.64 |
| Upper Bollinger Bands | 1.47 |
| Lower Bollinger Band | 1.16 |
| Percent B (%b) | 0.51 |
| BandWidth | 23.17 |
| MACD Line | -0.08 |
| MACD Signal Line | -0.09 |
| MACD Histogram | 0.0093 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 1.62 | ||||
| Resistance 3 (R3) | 1.62 | 1.51 | 1.57 | ||
| Resistance 2 (R2) | 1.51 | 1.44 | 1.52 | 1.55 | |
| Resistance 1 (R1) | 1.42 | 1.39 | 1.47 | 1.42 | 1.54 |
| Pivot Point | 1.31 | 1.31 | 1.34 | 1.32 | 1.31 |
| Support 1 (S1) | 1.22 | 1.24 | 1.27 | 1.22 | 1.10 |
| Support 2 (S2) | 1.11 | 1.19 | 1.12 | 1.09 | |
| Support 3 (S3) | 1.02 | 1.11 | 1.07 | ||
| Support 4 (S4) | 1.02 |
